Amivantamab plus Chemotherapy in NSCLC with EGFR Exon 20 Insertions.
Caicun ZhouKe-Jing TangByoung Chul ChoBaogang LiuLuis Paz-AresSusanna ChengSatoru KitazonoMuthukkumaran ThiagarajanJonathan Wade GoldmanJoshua K SabariRachel E SanbornAaron S MansfieldJen-Yu HungMichael BoyerSanjay PopatJosiane Mourão DiasEnriqueta FelipMargarita MajemMahmut GumusSang-We KimAkira OnoJohn XieArchan BhattacharyaTrishala AgrawalS Martin ShreeveRoland E KnoblauchKeunchil ParkNicolas Girardnull nullPublished in: The New England journal of medicine (2023)
exon 20 insertions. (Funded by Janssen Research and Development; PAPILLON ClinicalTrials.gov number, NCT04538664.).